In 2024, forecasts indicate China's re-import of chloramphenicol at 460.39 kg, reflecting a notable decrease from 2023's figure. By 2025, the volume further declines to 396.17 kg, marking a decrease of 13.95% year-on-year from 2024. This downward trend continues, with 2026 showing another 15.87% reduction to 333.24 kg. The projection for 2027 predicts a further 18.52% fall, reaching 271.56 kg. By 2028, the forecast shows only 211.12 kg, a substantial decline overall, with a five-year compound annual growth rate (CAGR) indicating consistent negative growth, highlighting a significant reduction in re-imports over this period.

Future trends to watch for:

Evolving regulations affecting import and production in China could impact re-import volumes.
Domestic production improvements could reduce reliance on re-imports.
Changes in international trade policies and relations affecting pharmaceutical imports.